With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
Tag: Investors
-
Boston Scientific to acquire Penumbra for $14.5B
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.